NasdaqGS:AMRXPharmaceuticals
Reassessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Long Term Returns And A High Current P/E Ratio
Why Amneal Pharmaceuticals Is On Investors’ Radar Today
Amneal Pharmaceuticals (AMRX) has caught fresh attention after a period where the share price has been mixed, with a small 1 day gain, weaker recent month performance, and a stronger past 3 months and 1 year.
For investors, this creates a chance to reassess how the company’s current US$13.25 share price lines up with its recent business results, including revenue of US$3,018.76m and net income of US$72.06m, along with its value score of...